Target intelligence / Profile preview

Signal-transducing adaptor protein 2 (STAP2)

Target
STAP2
Molecular classification
Other (adaptor protein), Signal transduction protein
01

Overview

Signal-transducing adaptor protein 2 (STAP2) is a multifunctional intracellular adaptor protein that lacks intrinsic catalytic activity but mediates protein-protein interactions in various signal transduction pathways. It contains a pleckstrin homology (PH) domain at the N-terminus, a central Src homology 2 (SH2)-like domain, and a C-terminal proline-rich region with a YXXQ motif, important for binding proteins like STAT3. STAP2 is expressed in many tissues and cell types and regulates both adaptive and innate immune responses by connecting cell surface receptors (such as cytokine receptors, FcεRI, T-cell receptor, Toll-like receptor 4, c-Fms receptor) to downstream signaling molecules like STAT3, STAT5, MyD88, IKKβ, and others. It influences T-cell proliferation, differentiation, migration, and apoptosis, modulates B-cell and myeloid cell recovery/stress responses, supports memory CD8+ T cell maintenance, and is also implicated in cancer cell migration, proliferation, and resistance to certain tyrosine kinase inhibitors. As a signaling hub, dysregulation of STAP2 has been linked to inflammatory diseases and cancer progression, making it of potential therapeutic interest, though there are no known drugs that specifically target STAP2 directly at present.

Other names
STAP2BKSBRK substratebreast tumor kinase substrateBrk kinase substrate
02

Biological functions

Signal transductionRegulation of immune responses (adaptive and innate)T-cell activation and proliferationB-cell and myeloid cell regulationApoptosis regulation (Fas pathway)Chemotaxis/cell migrationCytokine productionModulation of insulin signaling
03

Disease associations

CancerInflammationImmune disordersTherapy resistance (notably in chronic myeloid leukemia)
04

Safety considerations

Involvement in immune cell activation may contribute to systemic inflammation if dysregulatedModulation of signaling pathways could potentially influence resistance to kinase inhibitors in cancer therapy

Beyond the preview

Go deeper on Signal-transducing adaptor protein 2 (STAP2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Signal-transducing adaptor protein 2 (STAP2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call